The PGRN Implementation Working Group provides a venue for members to collaborate on implementation research and to advance the field of clinical pharmacogenetics.
Purpose: The goal of the group is to share and collectively publish information on pharmacogenetics implementation priorities, strategies, metrics, and health-related outcomes associated with the use of pharmacogenetic information for clinical care. The ultimate goal is to advance pharmacogenetic testing, and through that improve drug related outcomes globally.
Opportunities: With its global membership, the PGRN enables multi-site studies of pharmacogenetic implementation on an international level, thereby increase the diversity of the populations included in studies in studies of pharmacogenetic testing and generalizability of the data.
Membership: The working group is open to all PGRN members who have implemented pharmacogenetic testing in practice or have interest in implementing testing.
Meetings: The group will meet twice monthly to discuss new project ideas and to provide updates on on-going projects. Stay tuned for the meeting schedule.
Interested in joining? All interested members are encouraged to attend the initial teleconference (to be scheduled for September 2023) or to contact Griffin Peters at email@example.com.
We are happy to announce that we have scheduled the new PGRN
Implementation Calls to take place on the first and third Wednesdays of the
month at 11 AM Eastern time. This group’s first call will take place next
Wednesday, September 20th at 11 AM ET.
Please note that you need to be a PGRN Member to take part in this initiative.
PGRN Implementation Working Group - Collaborative Agreement